The hunt for COVID-19 vaccine continues. An expert committee at the drug regulator's office has suggested changes to Serum Institute's trial protocols for Novavax Vaccine. Novavax is a US based company that has tied up with Serum in India.
CNBC-TV18’s Archana Shukla details the changes that are being sought by the expert panel.
